NCT06607692
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06607692
Title Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined with the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed). (LUPARPED)
Acronym LUPARPED
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Fundación de investigación HM
Indications
Therapies
Age Groups: child | adult
Covered Countries ESP

Facility Status City State Zip Country Details
HM Monteprincipe RECRUITING Boadilla del Monte Madrid 28660 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field